BOTHELL, Wash., Jan. 5 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, announced today that Michael Matysik, chief financial officer, will speak at the eighth annual Needham & Company Growth Conference on Tuesday, January 10, 2006, at 2:30 P.M. (Eastern Time). The conference is being held at the New York Palace Hotel from January 10-13, 2006.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )
Mr. Matysik will be discussing recent business highlights and related financial information regarding Cardiac Science Corporation. The presentation will be web cast live and will be available over the Internet at www.cardiacscience.com.
About Cardiac Science Corporation
Cardiac Science Corporation develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor -- defibrillators and cardiology data management systems. Cardiac Science Corporation also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services.
The company is the successor to various entities that have owned and operated cardiology related businesses, which sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science Corporation is headquartered in Bothell, WA, and also has operations in Lake Forest, California; Deerfield, Wisconsin; Shanghai, China; Copenhagen, Denmark and Manchester, United Kingdom.
Contact: Mike Matysik Senior vice president and chief financial officer 425-402-2009
Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comCardiac Science Corporation
CONTACT: Mike Matysik, Senior vice president and chief financial officerof Cardiac Science Corporation, +1-425-402-2009
Web site: http://www.cardiacscience.com/
